Article

SICS: effective solution to huge cataract problem

Small incision cataract surgery (SICS) is a highly desirable and effective technique for India and other countries in the eastern hemisphere because it provides a highly effective and economic treatment for the vast cataract population in that part of the world.

Small incision cataract surgery (SICS) is a highly desirable and effective technique for India and other countries in the eastern hemisphere because it provides a highly effective and economic treatment for the vast cataract population in that part of the world, said Dr Satyajit Sinha of the AB Eye Institute, Patma, India.

"India's population has just topped 1 billion. There are 16 million cataract patients, and two million are added every year," said Dr Sinha. "But there are just 16,000 ophthalmologists, with 10,000 operating, which means there is a huge patient load for each doctor. We need a simple and effective way to combat cataract."

In this context, the choice of surgery must be weighed against the pressing need for treatment. Extra capsular cataract extraction (ECCE) has a short learning curve, SICS a longer one, but phaco requires a difficult and lengthy apprenticeship. Complications caused by 'in-training calamities' are worse with phaco, Dr Sinha noted.

SICS has a number of advantages. It means earlier rehab for patients than ECCE. There are no complications with sutures or suture removal. It has advantages over phaco for grade three, four and five cataracts. Patients are happy, too.

"One side of the globe is phaco. But on the other side of the globe, where cost is a big factor, we use SICS," he said. "Now high-quality, low-cost surgical instruments are being made indigenously by Indian companies. You can buy a crescent and keratome for $2. You can perform a SICS surgery and buy the IOL for $20 per patient. Phaco machines, by contrast, are expensive," said Dr Sinha.

As a result, India has the most SICS surgeons in the world, and highest number of SICS training centres.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.